The (8;21) translocation between AML1 and ETO is a frequently- observed nonrandom genetic alteration associated with acute myeloid leukemia (AML). AML1 upregulates a number of target genes critical to normal hematopoiesis, whereas the AML1-ETO fusion interferes with this function. We discovered that the fusion partner ETO binds to the human nuclear receptor co-repressor (N-CoR). Human N-CoR, which we cloned and sequenced in its entirety, encodes a 2,440 amino-acid polypeptide and has a bipartite central domain that binds ETO. N-CoR, Sin3, and histone deacetylase form a complex that alters chromatin structure and mediates transcriptional repression by nuclear receptors and by a number of onco-regulatory proteins. We determined that ETO, either alone or as part of the AML1-ETO fusion, could bind to the N-CoR complex. As a result of this interaction, ETO can function as a potent repressor of transcription. Our observations provide a novel mechanism for how the AML1-ETO fusion inhibits expression of AML1-responsive target genes and disturbs normal hematopoiesis. Based upon this new information, we are now testing the hypothesis that inhibitors of histone deacetylase may serve as a specific means of """"""""de-repressing"""""""" hematopoietic target genes in patients with t(8;21) AML.
| Wood, J D; Nucifora Jr, F C; Duan, K et al. (2000) Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription. J Cell Biol 150:939-48 |
| Li, J; Wang, J; Wang, J et al. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19:4342-50 |
| Stacey, M W; Wang, J; Byrd, R L et al. (1999) Nuclear receptor co-repressor gene localizes to 17p11.2, a frequently deleted band in malignant disorders. Genes Chromosomes Cancer 25:191-3 |
| Redner, R L; Wang, J; Liu, J M (1999) Chromatin remodeling and leukemia: new therapeutic paradigms. Blood 94:417-28 |
| Wang, J; Saunthararajah, Y; Redner, R L et al. (1999) Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res 59:2766-9 |
